Anti-influenza virus compound from Streptomyces sp. RI18. 2010

Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
Biomedicinal Information Research Center (BIRC), Japan Biological Informatics Consortium (JBIC), 2-4-7 Aomi, Koto-ku, Tokyo 135-0064, Japan. motoki-takagi@aist.go.jp

Screening for anti-influenza virus activity in compounds isolated from Streptomyces sp. RI18, which was isolated using the membrane filter method, uncovered a novel compound, JBIR-68 (1), which contains a unique skeleton. Its structure was established by extensive NMR and MS analyses. In addition, 1 was synthesized to confirm the configuration of its sugar moiety. Compound 1 inhibited influenza virus growth in plaque assays.

UI MeSH Term Description Entries
D009005 Monosaccharides Single chain carbohydrates that are the most basic units of CARBOHYDRATES. They are typically colorless crystalline substances with a sweet taste and have the same general formula CnH2nOn. Monosaccharide,Simple Sugar,Simple Sugars,Sugar, Simple,Sugars, Simple
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
October 2016, The Journal of antibiotics,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
September 2020, Marine drugs,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
March 2022, Fitoterapia,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
December 2013, The Journal of antibiotics,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
July 2010, The Journal of antibiotics,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
November 2018, The Journal of antibiotics,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
November 2022, The Journal of general and applied microbiology,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
April 2023, Journal of natural products,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
July 1990, Antiviral research,
Motoki Takagi, and Keiichiro Motohashi, and Aya Nagai, and Miho Izumikawa, and Masahiro Tanaka, and Shinichiro Fuse, and Takayuki Doi, and Keiichiro Iwase, and Atsushi Kawaguchi, and Kyosuke Nagata, and Takashi Takahashi, and Kazuo Shin-ya
July 2020, Journal of Asian natural products research,
Copied contents to your clipboard!